Minovia Therapeutics
Shmulik Polak has a strong background in finance and audit, having worked in various roles including Director of Finance and Senior Auditor. With experience in both public and private sectors, Shmulik has led fundraising efforts and controlled financial processes. Shmulik holds a CPA degree in Accounting and a Bachelor's degree in Health Care Administration/Management.
This person is not in any teams
This person is not in any offices
Minovia Therapeutics
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.